Viva Biotech Holdings (FRA:VB0) EPS without NRI: €0.01 (TTM As of Dec. 2025)


FRA:VB0 Viva Biotech Holdings FRA:VB0
43 GF Score
Price €0.14
GF Value €0.09
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Viva Biotech Holdings EPS without NRI?

Viva Biotech Holdings FRA:VB0 +6.20% 43 EPS without NRI is €0.01 as of Dec. 2025. GuruFocus rates FRA:VB0 with a GF Score™ of 43/100 and a GF Value™ of €0.09 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,170 Biotechnology companies, Viva Biotech Holdings ranks worse than 85470% on this metric.

Viva Biotech Holdings's earnings per share without non-recurring items for the six months ended in Dec. 2025 was €0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.

During the past 12 months, Viva Biotech Holdings's average earnings per share (NRI) Growth Rate was -52.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Viva Biotech Holdings's EPS without NRI or its related term are showing as below:

During the past 10 years, Viva Biotech Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 135.10% per year. The lowest was -22.70% per year. And the median was 18.50% per year.

FRA:VB0's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.75
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Viva Biotech Holdings's EPS (Diluted) for the six months ended in Dec. 2025 was €0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.

Viva Biotech Holdings's EPS (Basic) for the six months ended in Dec. 2025 was €0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.


Viva Biotech Holdings  (FRA:VB0) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Viva Biotech Holdings EPS without NRI Related Terms


Viva Biotech Holdings EPS without NRI Historical Data

* Premium members only.

The historical data trend for Viva Biotech Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viva Biotech Holdings EPS without NRI Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 -0.01 0.01 0.01 0.01

Viva Biotech Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.00 0.00 0.01 0.00

FRA:VB0 vs VRTX, REGN, ALNY: EPS without NRI Comparison

For the Biotechnology subindustry, Viva Biotech Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viva Biotech Holdings PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's PE Ratio without NRI falls into.


FRA:VB0
43GF Score
Viva Biotech Holdings FRA:VB0
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viva Biotech Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €0.01 mean?
Viva Biotech Holdings (FRA:VB0) has a EPS without NRI of €0.01 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Viva Biotech Holdings and its competitors. According to the industry distribution chart, Viva Biotech Holdings ranks #999999 out of 1170 companies in the Biotechnology industry.
Is Viva Biotech Holdings' EPS without NRI too high?
Viva Biotech Holdings' current EPS without NRI is €0.01. Based on the distribution chart, Viva Biotech Holdings ranks #999999 out of 1170 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Viva Biotech Holdings has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viva Biotech Holdings' EPS without NRI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Viva Biotech Holdings ranks #999999 out of 1170 companies for EPS without NRI. This places Viva Biotech Holdings in the lower half of its industry. The industry median EPS without NRI is 16.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.75, based on 1,170 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Viva Biotech Holdings and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viva Biotech Holdings's current EPS without NRI is €0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viva Biotech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Viva Biotech Holdings (FRA:VB0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.09, compared to a current price of €0.14 — trading 52.2% above its estimated fair value. The current EPS without NRI is €0.01. Viva Biotech Holdings' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Viva Biotech Holdings (FRA:VB0), the current EPS without NRI is €0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viva Biotech Holdings (FRA:VB0) Overvalued in 2026?

Based on GuruFocus' analysis, Viva Biotech Holdings stock appears to be overvalued. The current stock price of €0.14 is trading 52.2% above its estimated GF Value™ of €0.09. GuruFocus considers Viva Biotech Holdings to be Significantly Overvalued.

Key valuation signals for FRA:VB0:

  • EPS without NRI: €0.01
  • GF Value™: €0.09 vs. price of €0.14 (52.2% above fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the FRA:VB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viva Biotech Holdings Business Description

Other Exchanges VBIZF:USA01873:Hong Kong
Address 735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
43GF Score

Get the complete analysis for FRA:VB0

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.09
GF Value